Aspire BioPharma is trading 5.2% up at $5.90 in pre-market, extending a technical rebound after yesterday’s steep 22.6% drop to $5.61.
- Market participants cite bargain-hunting and thin liquidity as the primary drivers of the move, rather than new fundamental catalysts like earnings or FDA decisions.
- The recovery comes amid a modestly firmer broader market tone, with index futures trading slightly higher.